Ph-Negative ALL
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Blinatumomab Followed by High-dose Chemotherapy for Ph-negative Acute Lymphoblastic Leukemia (ALL) (NCT04554485) | Institute of Hematology and Blood Transfusion, Czech Republic | 2019-05-09 |
Track Ph-Negative ALL automatically
Every clearance here is in the API, with alerts when new ones post.